Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Recruiting 2Terminated 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Breast 1

Conditions

Breast Neoplasms 5Colorectal Neoplasms 4Hematopoietic and Lymphatic System Neoplasm 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psychological Well-Being 1Prostatic Neoplasms 1Neoplasms 1Cardiovascular Diseases 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Screening 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Patient Navigation × Clear all
NCT06070870 2026-03-16

HEALS

Virginia Commonwealth University

Phase NA Recruiting
675 enrolled
Thoracic

Lung Neoplasms

NCT05978128 2025-11-10

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Jonsson Comprehensive Cancer Center

Phase NA Recruiting
800 enrolled
BreastThoracic

Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡